Cancer cells adapt and undergo changes in their lipid metabolism; they acquire a lipogenic phenotype by expressing high levels of monoacylglycerol lipase (MAGL), which regulates the pro-tumorigenic lipid network that supports tumor progression (Nomura et al., 2010). This evidence concerns the gene MGLL and neoplasm.